Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 1 chart position in 1 market.
By chart position
- 🇻🇳VN · Science#773K to 10K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
1.5K to 5K🎙 ~2x weekly·300 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
3K to 10K🇻🇳100% - Active Followers
Loyal subscribers who consistently listen
900 to 3K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 20 epsHosts
Recent guests
Recent episodes
The Urology-Oncology Partnership in ADCs
Jul 15, 2026
6m 27s
A Team Approach to ADCs in Bladder Cancer
Jul 8, 2026
9m 59s
MDS: Low Risk Isn't No Risk
Jun 30, 2026
21m 37s
Beyond Body Art: Restoring Wholeness Through Paramedical Tattooing
Jun 23, 2026
14m 50s
Bridging Radiation and Oncology in SCLC Care
Jun 19, 2026
12m 29s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/15/26 | urology-oncology partnershipantibody-drug conjugates+3 | Manojkumar Bupathi, MD | enfortumab vedotinpembrolizumab+2 | Denver, CO | antibody-drug conjugatebladder cancer+5 | — | 6m 27s | ||
| 7/8/26 | bladder cancermultidisciplinary team+3 | Terence Friedlander, MDIva Petrovchich Colón, NP | University of California, San FranciscoZuckerberg San Francisco General Hospital+3 | — | bladder cancerantibody-drug conjugates+3 | — | 9m 59s | ||
| 6/30/26 | Myelodysplastic syndromesrisk assessment+3 | Amy DeZern, MD, MHSChristin Blair DeStefano, MD, FACP | Sidney Kimmel Comprehensive Cancer CenterWalter Reed National Military Medical Center | Baltimore, MDBethesda, MD | MDSlow risk+3 | — | 21m 37s | ||
| 6/23/26 | breast cancerparamedical tattooing+3 | Taylor KeeneyEraina Bartholomew | TayK CosmeticsCANCER BUZZ | — | breast cancerparamedical tattooing+3 | — | 14m 50s | ||
| 6/19/26 | radiation therapysmall cell lung cancer+3 | Charles B. Simone, II, MD, FASTRO, FACRO, FACR | New York Proton CenterMemorial Sloan Kettering Cancer Center | New York, NY | radiation oncologySCLC+3 | — | 12m 29s | ||
| 6/10/26 | bispecific antibodiesimmunotherapy+3 | Nicholas Burwick, MD | Association of VA Hematology/OncologyPuget Sound VA Health Care System+1 | — | bispecific antibodiesimmunotherapy+3 | — | 14m 05s | ||
| 6/3/26 | toxicity managementantibody-drug conjugates+3 | Cindy Y. Jiang, MD | enfortumab vedotinpembrolizumab+2 | Houston, TX | toxicity managementantibody-drug conjugates+5 | — | 7m 42s | ||
| 5/27/26 | cancer careglobal health+4 | Michael Cavnar | UK HealthCare/Markey Cancer CenterACCC | ZambiaLexington, KY | cancer careZambia+5 | — | 5m 07s | ||
| 5/12/26 | Value-Based CareOncology+3 | Misha Kaur | CureetyACCC+1 | — | value-based careoncology+3 | — | 8m 03s | ||
| 5/11/26 | health policyoncology+4 | Jay Seemann | BeOne MedicinesACCC | — | health policycancer care+4 | — | 6m 10s | ||
| 5/5/26 | oncologyinnovation+3 | Michele LeSueur, DBA | Johnson & JohnsonAssociation of Cancer Care Centers+2 | — | oncologyinnovation+4 | — | 6m 26s | ||
| 5/4/26 | AI in OncologyOncology Leadership+3 | Ashley Johnson | LeanTaasAssociation of Cancer Care Centers+1 | — | AI toolsoncology+4 | — | 6m 15s | ||
| 4/21/26 | bispecific antibodiesoncology+3 | Laura Kuzma | FirstHealth Cancer CenterFirstHealth Moore Regional Hospital | Pinehurst, NC | bispecific antibodiesoncology+5 | — | 16m 53s | ||
| 4/7/26 | oncologycancer care+4 | Meagan O'Neill | CAR T-cell therapyAssociation of Cancer Care Centers+3 | — | ACCCImpact Report+5 | — | 5m 41s | ||
| 3/18/26 | palliative careoncology+3 | Andrew Ambort, DO | WellSpan HealthACCC | — | palliative careoncology+3 | — | 26m 04s | ||
| 3/3/26 | TIL cell therapymelanoma+3 | Lilit Karapetyan, MD, MS, FACPRaju Vaddepally, MD | Moffitt Cancer Center and Research InstituteFlorida Cancer Specialists+1 | — | TIL cell therapymelanoma+3 | — | 12m 51s | ||
| 2/17/26 | oncologyhealth policy+3 | Martin Palmeri, MD, MBA, FASCOPatricia Serna, MHS, PA-C, CGRA+1 | Messino Cancer CentersTexas Oncology+3 | — | oncologypolicy+3 | Johnson & Johnson | 20m 11s | ||
| 2/5/26 | psychosocial distresspsychedelic-assisted therapy+4 | Judy WightJennifer Bires+1 | Life with CancerInova Health System+2 | — | psychedelic therapycancer survivors+5 | — | 29m 04s | ||
| 1/29/26 | health careinnovation+4 | Michelle Rozen, PhD | Association of Cancer Care Centers | — | health careinnovation+5 | — | 9m 21s | ||
| 1/28/26 | cancer careACCC plans+4 | Meagan O'Neill | Association of Cancer Care Centers | — | cancer careACCC+5 | — | 22m 25s |
Showing 20 of 20
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for CANCER BUZZ
Peaked at #77 in VN, currently #77 in VN.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| VN | — | #77 | #77 | — |
Chart Positions
1 placement across 1 market.
Chart Positions
1 placement across 1 market.